AUTHORS’ CONTRIBUTIONS
WG‐M: designed the study, performed laboratory testing, analysed data and drafted the manuscript; EP‐M: HPTN 071 LC QA/QC Representative; WC: responsible for antiretroviral drug testing; AB: performed antiretroviral drug testing; KBZ: assisted with data management; AM: HPTN 071 Study Coordinator; HMA: HPTN 071 Zambia Site PI; BK: provided laboratory support for HPTN 071 in Zambia; KS: HPTN 071 (PopART) Zambia Site Investigator; PB: HPTN 071 South African Site Co‐PI; SAM: HPTN 071 Research Manager in South Africa; GM: provided laboratory support for HPTN 071 in South Africa; SF: HPTN 071 Protocol Co‐Chair; RH: HPTN 071 Protocol Chair; DD: HPTN 071 Statistician; SHE: HPTN 071 Virologist, designed the study, analysed data and drafted the manuscript. All authors contributed to the manuscript and approved the submitted version.